ASX · CSL.AX
CSL Limited
A$200.73+A$3.23 (+1.64%)
CSL Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
Loading market information…
ASX · PKP.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 04:53 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Peak Processing Limited’s quoted price sits in the lower half of its reported 52-week range, 33.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Peak Processing Limited’s next earnings report is currently expected on Feb 24, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Peak Processing Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Melbourne, Australia, and founded in 2016, Peak Processing Limited, alongside its subsidiaries, is engaged in the manufacturing, distribution, and sale of recreational cannabis products throughout Canada and the United States. Its extensive product line, available through retail outlets, features items such as beverages, hydrocarbon extracts, various oils, vapes, topicals, powders, infused flowers, and edibles. Furthermore, the company provides a suite of services, including market analysis, product development, production, commercialization strategies, logistical distribution, and product refurbishment. Notably, the firm was previously known as Althea Group Holdings Limited and is slated to officially change its name to Peak Processing Limited in November 2025.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:05 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
A$200.73+A$3.23 (+1.64%)
CSL Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
A$2.73+A$0.01 (+0.37%)
Sigma Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 14.69% below the high.
A$196.20-A$0.89 (-0.45%)
Pro Medicus Limited’s quoted price sits in the upper half of its reported 52-week range, 28.09% below the high.
A$55.60+A$0.68 (+1.24%)
Ramsay Health Care Limited’s quoted price sits in the upper half of its reported 52-week range, 0.89% below the high.
A$19.57+A$0.50 (+2.62%)
Sonic Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 19.37% below the high.
A$143.64+A$1.44 (+1.01%)
Cochlear Limited’s quoted price sits in the lower half of its reported 52-week range, 50.67% below the high.
A$45.44+A$0.32 (+0.71%)
Ansell Limited’s quoted price sits in the upper half of its reported 52-week range, 2.84% below the high.
A$13.13-A$0.35 (-2.6%)
Telix Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 27.94% below the high.
